Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.121011 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Mariska Bot und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Public Health, Mental Health Program, De Boele…. Hauptthemen laut MEDLINE: Antidepressive Agents, Major Depressive Disorder, Sertraline, Citalopram. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Netherlands Organisation for Health Research and Development.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: There is considerable variability in how patients respond to antidepressants. Currently, rates of sustained symptomatic remission (i.e. stable remission) and factors associated with stable remission are unclear. Here, we study onset of stable remission and its associated sociodemographic and clinical factors in patients with depression who recently started antidepressant medication. METHOD: Data were obtained from the observational, naturalistic OPERA-monitor out-patient cohort, including 591 adults with depression who started citalopram or sertraline within the past six months. Between June 2019 to January 2024, participants completed surveys every two months for up to 24 months. Multivariable Cox proportional hazard models were used to identify factors associated with onset of stable remission, defined as 1) two subsequent Inventory of Depressive Symptomatology Self Report (IDSSR) scores ≤21, and 2) six-month absence of major depressive disorder (Simplified Mini-International Neuropsychiatric Interview). RESULTS: Over a median follow-up duration of 0.87 years, 278 (47 %) out of 591 participants reached stable remission (0.46 events per person-year), of which 183 did so within one year after starting antidepressants. Higher antidepressant dose (hazard ratio (HR) 0.73; 95 % confidence interval (CI) 0.57-0.94), and higher IDS depression score (HR 0.94; 95 %CI 0.93-0.96) were independently associated with a lower likelihood of stable remission. CONCLUSIONS: Nearly half of patients starting antidepressant medication reached stable remission. Higher depressive symptoms and higher dose - both likely reflecting more severe depression - were associated with lower remission rates. Findings highlight the need to identify and address factors hindering stable remission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Public Health, Mental Health Program, De Boelelaan 1117, 1081 HV, Amsterdam, the Netherlands. Electronic address: m.…
- Department of Primary and Community Care, Radboud university medical center Research Institute for Medical Innovation, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
- Department of Primary and Long-term Care, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.
- Department of Psychiatry, Erasmus MC University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
- Department of Public Health and Primary Care, Leiden University Medical Centre, Albinusdreef 2, 2333 ZG, Leiden, the Netherlands.
- Department of Psychiatry, Research School of Behavioral and Cognitive Neurosciences (BCN), Interdisciplinary Center Psychopathology of Emotion Regulation (ICPE), University Medical Center Groningen, University of Gronin…
Förderung
- Netherlands Organisation for Health Research and Development
Zitieren
APA
Bot, M., Ligthart, S. A., Burger, H., Grootendorst-van Mil, N. H., Arnold, I. A., van Belkum, S. M., Bet, P. M., Birkenhager, T. K., Göttgens, W., Hugtenburg, J. G., Maarsingh, O. R., Ruhé, H. G., Spijker, J., Vinkers, C. H., & Penninx, B. W. J. H. (2026). Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.121011
Vancouver
Bot M, Ligthart SA, Burger H, Grootendorst-van Mil NH, Arnold IA, van Belkum SM, et al. Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.121011
BibTeX
@article{Bot2026,
author = {Bot, Mariska and Ligthart, Suzanne A and Burger, Huibert and Grootendorst-van Mil, Nina H and Arnold, Ingrid A and van Belkum, Sjoerd M and Bet, Pierre M and Birkenhager, Tom K and Göttgens, Wilma and Hugtenburg, Jacqueline G and Maarsingh, Otto R and Ruhé, Henricus G and Spijker, Jan and Vinkers, Christiaan H and Penninx, Brenda W J H},
title = {Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.121011}
}
EUVIMED